Outcome analysis and cost assessment in immunologic disorders

Keyphrases

• Outcome Costs 100%
• Serious Illness 100%
• Interferon-γ 100%
• Cost Evaluation 100%
• Outcome Analysis 100%
• Immunological Disorders 100%
• Immune Response 50%
• Medical Illness 50%
• Biological Agents 50%
• Intravenous Immunoglobulin (IVIg) 50%
• Cost-effectiveness 50%
• Organ Damage 50%
• Infection Rate 50%
• Hospital Admission 50%
• Drug Costs 50%
• Chronic Granulomatous Disease 50%
• Antibody Deficiency 50%
• Cost of Illness 50%
• Gamma Treatment 50%

Immunology and Microbiology

• Interferon Gamma 100%
• Immunopathology 100%
• Immune Response 50%
• Biological Product 50%
• Intravenous Immunoglobulin 50%
• Chronic Granulomatous Disease 50%
• Humoral Immune Deficiency 50%

Pharmacology, Toxicology and Pharmaceutical Science

• Disease 100%
• Immunopathology 100%
• Gamma Interferon 50%
• Infection 25%
• Biological Product 25%
• Immunoglobulin 25%
• Chronic Granulomatous Disease 25%
• Humoral Immune Deficiency 25%